Online article for Non-subscribers

Pay per view

Heterocycles has a pay-per-view service for Non-subscribers.
You will be able to directly purchase the full text article through PayPal.
Your purchased Paper can be downloaded after the payment is completed.
An e-mail will be sent the URL to download the paper.
If you have any questions, please contact:

Price: ¥ 4,400 (Yen only)
Period: This Article can be accessed for 7 days.

Paper | Special issue | Vol 99, No. 2, 2019, pp.942-957
Published online, 14th December, 2018
DOI: 10.3987/COM-18-S(F)60
Synthesis, Conformation, and Biological Activities of a Des-A-Ring Analog of 18-Deoxy-Aplog-1, a Simplified Analog of Debromoaplysiatoxin

Yoshiki Ashida, Ryo C. Yanagita,* Yasuhiro Kawanami, Mutsumi Okamura, Shingo Dan, and Kazuhiro Irie

*Department of Applied Biological Science, Faculty of Agriculture, Kagawa University, 2393 Ikenobe, Miki, Kagawa 761-0795, Japan


10-Me-Aplog-1 as a simplified analog of tumor-promoting debromoaplysiatoxin and a potent activator of protein kinase C (PKC) is a promising chemotherapeutic agent. In this study, we synthesized a des-A-ring analog (4) of 18-deoxy-aplog-1 as a synthetically-accessible analog. Compound 4 retained the conformation of the PKC-recognition part of aplogs. Moderate affinity for conventional PKC isozymes (α, β, γ) and anti-proliferative activity against NCI-H460 (lung) and MKN45 (stomach) human cancer cell lines were observed. The results suggest that 4 could serve as a lead compound for the development of conventional PKC isozyme-selective chemotherapeutic agents.